| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/ATVBAHA.108.162768 |
| P8608 | Fatcat ID | release_pwsxvwlz45hunaiz4ltcu4ys7q |
| P698 | PubMed publication ID | 18276906 |
| P5875 | ResearchGate publication ID | 5574978 |
| P50 | author | Luc Rochette | Q37829991 |
| Pierre Sicard | Q42800230 | ||
| Catherine Vergely | Q57018162 | ||
| Yves Cottin | Q57304161 | ||
| Luc Lorgis | Q88510625 | ||
| Marianne Zeller | Q91761128 | ||
| Laurence Duvillard | Q114424107 | ||
| Claudia Korandji | Q114424109 | ||
| Jean-Claude Guilland | Q114424110 | ||
| Jean-Claude Beer | Q114424111 | ||
| Anne-Cécile Lagrost | Q114424112 | ||
| Philippe Gambert | Q114424113 | ||
| P2093 | author name string | Daniel Moreau | |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 954-960 | |
| P577 | publication date | 2008-02-14 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction | |
| P478 | volume | 28 |
| Q38112398 | Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects |
| Q35966113 | Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris |
| Q36182184 | Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies |
| Q46344031 | Asymmetric dimethylarginine (ADMA): A cardiovascular risk factor |
| Q37704715 | Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis |
| Q37211043 | Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease |
| Q37728774 | Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus |
| Q35247030 | Asymmetric dimethylarginine triggers macrophage apoptosis via the endoplasmic reticulum stress pathway |
| Q35762008 | Asymmetrical dimethylarginine and severity of erectile dysfunction and their impact on cardiovascular events in patients with acute coronary syndrome |
| Q35686992 | Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction |
| Q64072690 | Blockade of Cardiac Proton Pump Impairs Ventricular Remodeling Through a Superoxide-DDAH-Dependent Pathway in Infarcted Rats |
| Q35757606 | Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy |
| Q84755621 | Elevated preoperative serum asymmetrical dimethylarginine (ADMA) is associated with poor outcomes after pediatric cardiac surgery |
| Q51065329 | Endothelial dysfunction, inflammation and malnutrition markers as predictors of mortality in dialysis patients: multimarker approach. |
| Q30474155 | Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment |
| Q37096680 | Heat-assisted extraction for the determination of methylarginines in serum by CE. |
| Q36908856 | High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction |
| Q36260985 | Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction |
| Q37367182 | L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis |
| Q36150527 | Levels and values of circulating endothelial progenitor cells, soluble angiogenic factors, and mononuclear cell apoptosis in liver cirrhosis patients |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q34167247 | Optimization of the separation of NDA-derivatized methylarginines by capillary and microchip electrophoresis. |
| Q36590608 | Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1. |
| Q42936427 | Ratio Of Serum Asymmetric Dimethyl Arginine (ADMA)/ Nitric Oxide in Coronary Artery Disease patients |
| Q38680894 | Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction, infarct size and reverse remodeling in ST-elevation myocardial infarction. |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q35985806 | Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease |
| Q33940891 | The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease |
| Q37608226 | The emerging role of symmetric dimethylarginine in vascular disease |
| Q37858880 | The role of asymmetric and symmetric dimethylarginines in renal disease |
| Q43493575 | Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease |
Search more.